Clayton Financial Group’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-234
Closed -$82.3K 89
2026
Q1
$82.3K Hold
234
0.04% 112
2025
Q4
$76.6K Buy
234
+212
+964% +$67.2K 0.04% 122
2025
Q3
$6.21K Buy
+22
New +$6.38K ﹤0.01% 162

Other funds holding AMGN

Clayton Financial Group's AMGN Position: Q2 2026 in Review

Clayton Financial Group sold out of Amgen (AMGN) in Q2 2026, closing a stake of 234 shares — an estimated $82.3K sold.

Clayton Financial Group first reported a position in AMGN in Q3 2025 and held it in 3 quarters. The position peaked at $82.3K in Q1 2026. 1,264 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Clayton Financial Group reported no remaining Amgen position as of Q2 2026 after selling out during the quarter.
  • Clayton Financial Group sold 234 Amgen shares in Q2 2026, an estimated $82.3K.
  • Clayton Financial Group first reported a position in Amgen in Q3 2025 and held it in 3 quarters.
  • Clayton Financial Group's Amgen position peaked at $82.3K in Q1 2026.
  • 1,264 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Clayton Financial Group's 13F filing for Q2 2026, filed 20 Jul 2026.